Deregulation of glutamine metabolism was observed in CRC, associated with PIK3CA mutations that render cancer cells more dependent on glutamine by upregulating glutamate-pyruvate transaminase 2 (GPT2)9. This evidence concerns the gene GPT2 and cancer.